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ABSTRACT 
 
THE EFFECT OF BEVACIZUMAB ON α-SMOOTH MUSCLE ACTIN 
EXPRESSION AND FIBROBLAST COUNT IN TRABECULECTOMY 
AREA TOWARDS PREVENTION OF FIBROSIS 
(Experimental Study on Oryctolagus cuniculus) 
 
Sekar Ayu Sitoresmi, Nurwasis, Evelyn Komaratih, Heriyawati 
 
 
Objective: to analyze the effect of bevacizumab on α-smooth muscle actin 
expression and fibroblast count in trabeculectomy area of rabbit models in order 
to find a safer modulator of wound healing to improve surgical outcome. 
Material and methods: 16 New Zealand white rabbits aged 4-6 months and 
weigh between 2,5-3,5 kg were performed trabeculectomy in their right eyes with 
postoperative subconjunctival injection of BSS and Bevacizumab. Rabbits were 
put into control and bevacizumab group using simple random sampling. 
Examination were done postoperative day 1, 7, and 14 and subjects were 
terminated and performed enucleation on postoperative day 14. The samples were 
histologically stained with Haematoxyline-Eosin to count the fibroblast and 
immunohistochemistry using α-smooth muscle actin antibody to differ the 
myofibroblast from fibroblast and the expression of α-SMA were collected using 
immunoreactive score. 
Result: Mann Whitney u test and independent t-test were used to analyze the data, 
and we found both less expression of α-smooth muscle actin and fibroblast count 
on bevacizumab group compared to control group which indicates less 
myofibroblast, fibroblast, and less scarring potential in trabeculectomy area. 
Conclusion: bevacizumab inhibits fibroblast proliferation and its differentiation 
to myofibroblast that lead to less collagen production and fibrosis. 
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